Oral Hyaluronic Acid: What Trials Show (Not Like HA Injections)

By Erin Rose · Updated July 19, 2026 · Methodology

Educational overview — not medical advice. This page covers ORAL (ingested) hyaluronic acid supplements only, a separate product from HA dermal filler injections and topical HA skincare serums; oral evidence does not transfer to either. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

As an Amazon Associate we earn from qualifying purchases. On best hyaluronic acid, products are ranked by trial-dose match and trial-matched ingredient first, price second — not by commissions.

Start here

What oral HA is, and the three evidence threads

Hyaluronic acid (HA) is a large polysaccharide the body already makes and uses to hold water in skin, joints, and connective tissue — it's not an essential nutrient, so there's no deficiency state, no RDA, and no government-set upper limit; any claimed benefit of supplementing has to stand on its own trial evidence, the way it does for a non-essential compound rather than a vitamin correcting a shortfall. Twelve verified human and animal studies make up the oral-HA evidence base, splitting into three threads. First, skin hydration and wrinkle depth is the largest and most-replicated pocket: Oe 2017 (n=60, 12 weeks) and Hsu 2021 (n=40, 12 weeks) are the two strongest, both double-blind and placebo-controlled at 120mg/day, both finding measurable improvement in wrinkle measures and skin water content from around week 8. But read the funding line every time: most authors on both trials are employed by Kewpie Corporation, which also makes the Hyabest HA ingredient the trials used — see the full breakdown. Second, knee osteoarthritis evidence is thinner and dose-inconsistent: Tashiro 2012 tested 200mg/day of plain HA for 12 months and found age-dependent symptom improvement, while Nelson 2015 tested only 80mg/day of a completely different branded ingredient (Oralvisc/Hyal-Joint DS) for 3 months. Two trials, two ingredients, two doses — not one settled "joint dose." Third, a single small pilot trial (Kim 2019) tested oral HA as an add-on to topical drops for dry eye, not as standalone evidence.

Does it work? (the honest short version)

For skin, modestly and with a funding caveat that has to be stated every time: hydration and wrinkle-depth measures improve in small trials at 120mg/day over 8-12 weeks, and the finding replicates across four separate small studies — but three of the four strongest trials share Kewpie-affiliated co-authors, the maker of the Hyabest ingredient tested. A broader 2022 meta-analysis (Sun 2022) found a significant pooled hydration effect across several skin-moisturizing supplements including HA — it is not an HA-exclusive review, and shouldn't be cited as one. For joints, the evidence is real but genuinely modest and does not add up to a proven osteoarthritis treatment: Tashiro's benefit faded in patients over 70, and Nelson's positive trial used a different ingredient at a lower dose entirely. Nothing here is a substitute for medical OA management, and nothing here is evidence for HA injections into the joint, which are a different procedure with a different evidence base.

The buying problem

Because "hyaluronic acid supplement" actually covers three different product types, the milligram number on the front of a bottle can mean three different things. Plain sodium hyaluronate capsules (Jarrow, NOW, Nutricost) are chemically identical HA, but the specific branded product was never itself put through a trial — only the compound class was. Hyabest (Natural Factors) is the specific fermentation-derived ingredient that Oe 2017 and Hsu 2021 actually used, and comes from the same Kewpie research program that developed the ingredient behind Kawada 2014 — it has a higher total bottle price ($34.97) but is NOT more expensive per mg of HA; at 60 servings it's actually slightly cheaper per mg than the plain generics. And BioCell Collagen (Doctor's Best) bundles HA with collagen type II and chondroitin sulfate, where HA is a disclosed minority component (roughly 100mg within a 1000mg blend) — not the ingredient being dosed, and not a fair mg-for-mg price comparison against the plain products. The full ranking keeps these three categories honestly separated instead of comparing them as if interchangeable.

Safety

No serious adverse events have been reported across the RCTs in this evidence base, at doses from 80mg to 1g/day of combo products, over durations from 6 weeks up to Tashiro's 12-month OA trial — the longest human data point in this category. HA itself has a long history of use in food, cosmetics, and medicine, including injectable/medical contexts, which is a separate risk profile from oral supplementation. Two honest gaps: most human trial data is short-term (12 weeks or less, with Tashiro the notable 12-month exception), and no published dose-ranging safety study exists for oral HA the way there is for some other supplements, so there's no tested upper bound to cite. There's no dedicated pregnancy/breastfeeding trial data — default to clinician input because of the absence of data, not because of a specific harm signal.

Frequently asked questions

Related guides

• Collagen — the other skin-and-joint structural-protein supplement, with its own type/dose distinctions
• Astaxanthin — another skin-focused antioxidant with real-but-narrow human evidence
• Glucosamine — the other joint-cartilage supplement, often stacked with chondroitin
• Omega-3 — a joint-inflammation-adjacent supplement with a much larger trial base

Sources